Irisin Predicts Poor Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Low Levels of N-Terminal Pro-B-Type Natriuretic Peptide

Background: Despite existing evidence of the high predictive value of natriuretic peptides (NPs) in patients with heart failure (HF), patients treated with guideline-directed therapy who have low or near-normal NP levels are unlikely to be correctly stratified for risk of clinical outcomes. The aim...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tetiana A. Berezina, Oleksandr O. Berezin, Evgen V. Novikov, Michael Lichtenauer, Alexander E. Berezin
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2024-12-01
Edice:	Biomolecules
Témata:	heart failure with preserved ejection fraction clinical outcomes natriuretic peptide circulating biomarkers irisin visfatin
On-line přístup:	https://www.mdpi.com/2218-273X/14/12/1615
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!